{"id":1068246,"date":"2022-06-18T01:44:16","date_gmt":"2022-06-18T05:44:16","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/capricor-therapeutics-to-present-one-year-efficacy-results-from-its-ongoing-hope-2-open-label-extension-study-at-2022-parent-project-muscular\/"},"modified":"2024-08-18T11:44:52","modified_gmt":"2024-08-18T15:44:52","slug":"capricor-therapeutics-to-present-one-year-efficacy-results-from-its-ongoing-hope-2-open-label-extension-study-at-2022-parent-project-muscular","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/capricor-therapeutics-to-present-one-year-efficacy-results-from-its-ongoing-hope-2-open-label-extension-study-at-2022-parent-project-muscular.php","title":{"rendered":"Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular&#8230;"},"content":{"rendered":"<p><![CDATA[Results to be Presented in Late-Breaking Session Results to be Presented in Late-Breaking Session]]><\/p>\n<p>Here is the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/17\/2464709\/0\/en\/Capricor-Therapeutics-to-Present-One-Year-Efficacy-Results-from-its-Ongoing-HOPE-2-Open-Label-Extension-Study-at-2022-Parent-Project-Muscular-Dystrophy-Annual-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular...\">Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Here is the original post: Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/capricor-therapeutics-to-present-one-year-efficacy-results-from-its-ongoing-hope-2-open-label-extension-study-at-2022-parent-project-muscular.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068246","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068246"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068246"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068246\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}